UPL

Mumbai, India Founded: 1969 • Age: 57 yrs Listed Fortune India 500 · #61
Sustainable agriculture technologies and solutions are provided to farmers globally.
Request Access
Report Incorrect Data
Page last updated

About UPL

UPL is a publicly listed company based in Mumbai (India) founded in 1969. Sustainable agriculture technologies and solutions are provided to farmers globally. It operates in the Chemicals & Materials and Agriculture sectors. The company has 132 employees. UPL has completed 6 acquisitions, including Arysta LifeScience, BioQuim and Bioseen. Its chief executive, as recorded, is Mike Frank. Its website upl-ltd.com draws about 93 thousand monthly visits. Its Indian entity Upl Limited reported revenue of ₹52,753 Cr. Its focus areas include Chemicals and Materials Tech, Chemicals Tech, Green Chemicals and Crop Protection.

Company details

UPL was founded in 1969 in Mumbai, India, and operates in the agriculture sector. Crop protection solutions and smart farming practices are offered to farmers and agribusinesses. Emphasis is placed on OpenAg initiatives to support sustainable methods and innovative technologies. Operations extend internationally, with a focus on transforming agricultural processes through evidence-based approaches. Leadership is shared among co-CEOs, including Vikram Shroff.

UPL is ranked #61 on the Fortune India 500 (2025).

Recognitions & Rankings of UPL

Fortune India 500 2025 edition
Rank#61
Total income
₹47,123 Cr
Profit
₹897 Cr
Last year #62
India's Most Valuable Companies 2024 edition · Source: Hurun India
Rank#151
Valuation
₹41,710 Cr
2023 #116 2022 #70 2021 #77
  • Headquarters Mumbai, India
  • Employees 132
  • Stage Public
  • Sectors
    Chemicals & Materials
    Agriculture
  • Website category Heavy Industry and Engineering · Chemical Industry
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website upl-ltd.com
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Upl Limited
Operational Areas
Chemicals & Materials → Chemicals Tech
Agriculture → Crop Tech & Equipment
Key Metrics
  • Market Cap
    ₹46,811 Cr

    UPL · NSE

  • Share Price
    ₹562.15

    +1.34% today

  • Revenue
    ₹51,839 Cr

    FY 2025-26 · +11.2% YoY

  • EBITDA
    ₹8,888 Cr

    Margin 17.1%

  • Net Profit
    ₹1,785 Cr

    FY 2025-26 · +100.6% YoY

  • P/E (TTM)
    23.8x

    P/B 1.3x

  • ROE
    7.0%

    ROCE 11.6%

  • Debt / Equity
    0.76

    Interest cover 60.3x

  • Employee Count
    132
  • Investments & Acquisitions
    Arysta LifeScience

    & 5 more

Apps and channels of UPL

its YouTube channel UPL- Ltd has 11.2K subscribers and 30 videos.

UPL- Ltd
YouTube 11.2K subscribers 30 videos Nonprofits & Activism
Open channel

Videos from UPL

The most watched videos on UPL's YouTube channel, UPL- Ltd (11.2K subscribers). Click a video to play it here.

UPL Shashwat Mithaas Program, India
2.9K views
Sarus Crane Project: India
1.3K views
Jai Shroff at the World Economic Forum Annual Meeting 2023
1.1K views
UPL at FIFA World Cup 2022 recap
1.1K views

More on UPL- Ltd.

Funding Insights of UPL

  • Total Rounds 4
  • First Round $150M

    (Jun 2006)

  • Investors Count 1

All 4 funding rounds of UPL with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2018Post-IPO––
Nerka Chemicals
Mar 2018$300MDebt – Conventional––
–
Oct 2016$500MDebt – Conventional––
–
Jun 2006$150MPost-IPO––
–
Valuation history

1 investors in total: 1 institutional.

Investors in UPL

UPL has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Nerka Chemicals.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Nerka Chemicals
Agrochemicals are distributed by Nerka Chemicals in Ahmedabad, India.
Ahmedabad, India
Premium access

Investor details for UPL

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Upl Limited (UPL)

Upl Limited is the primary company behind UPL. The board of Upl Limited currently have 9 directors; the longest-serving is Jaidev Rajnikant Shroff, appointed in 1992. 18 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Jaidev Rajnikant Shroff
DIN 00191050
Director01 Oct 199234 yrs 1 moUpl Limited
Vikram Rajnikant Shroff
DIN 00191472
Director22 Apr 200620 yrs 6 moUpl Limited
Hardeep Singh
DIN 00088096
Director02 Feb 201511 yrs 9 moUpl Limited
Naina Lal Kidwai
DIN 00017806
Director01 Oct 20215 yrs 1 moUpl Limited
Suresh Kumar
DIN 00512630
Director20 Oct 20224 yrsUpl Limited
Raj Kumar Tiwari
DIN 09772257
Whole-time director01 Nov 20224 yrsUpl Limited
Usha Rao Monari
DIN 08652684
Director18 Aug 20233 yrs 2 moUpl Limited
Bhanumathi Viswanathan Melattur
DIN 10172983
Director01 Feb 20251 yr 9 moUpl Limited
Santosh Kumar Mohanty
DIN 06690879
Director06 Mar 20251 yr 8 moUpl Limited

People of UPL

513 people are tracked at UPL (158 in leadership, 5 in board & advisors, 350 in team); the tracked headcount is 132.

NameRoleGroup
Mike Frank
Co-CEOLeadership
Vikram Shroff
Co-CEOLeadership
Jai Shroff
Co-CEOLeadership
Ashutosh Singh
Exports Sales Head - Consumer ProductsLeadership
Raj Arora
Global Head of Supply Chain & ManufacturingLeadership
John Fred
Chief Legal OfficerLeadership
Rajendra Chanpuriya
Plant HeadLeadership
Mohan Rao
Global Head - Data Science & Tech DeliveryLeadership
Jagdish Nainwal
Region Head, LATAMLeadership
Rogerio Castro
Region Head, BrazilLeadership
Julian Montes Iannini
Business Director, Bio-solutions / Natural Plant ProtectionLeadership
Mayur Pawar
Head Strategic Sourcing-projectsLeadership
Dr.srinivasan Rengan
Head Regional Development & Regulatory - Asia PacificLeadership
Dr. Govind Sawant
Global Head - Stewardship And NPPL Asset RegulatoryLeadership
Diego Casanello
Global COO, Crop ProtectionLeadership
K. R. Srivastava
COO, Speciality ChemicalsLeadership
Mandar Kadam
Chief Financial OfficerLeadership
Jugal Doshi
Head Global Procurement - ChinaLeadership
Claudia Simion
Head Of Supply Chain MEDLeadership
Anna Scherzer
Head Of Procurement EuropeLeadership

493 more people are available in the full profile.

Premium access

Complete people profiles for UPL

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of UPL

UPL is a publicly listed company on the NSE with ticker symbol UPL in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date23 Jan 2004
  • Listed onNSE: UPL
  • Listed entityUPL Limited
  • Exchange sectorProcess industries
  • ISININE628A01036
  • Share price₹537.60 (+2.46% on the day) · 2026-10-14
  • Market capitalisation₹44,234 Cr
  • Price to earnings22.5
  • EPS (diluted, trailing year)₹23.92
  • Dividend yield1.17%
  • Volume (last session)1,907,670

Financials of UPL

Exchange-reported figures of Upl Limited, the listed company behind UPL (NSE: UPL).

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹51,839 Cr
+11.2% YoY
EBITDA
₹8,888 Cr
+32.3% YoY
Profit After Tax
₹1,785 Cr
+100.6% YoY
Net Worth
₹34,696 Cr
+18.8% YoY
Total Assets
₹65,391 Cr
+3.3% YoY
Total Debt
₹23,576 Cr
-6.1% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue51,83946,63743,09853,57646,24038,69435,756
Revenue growth+11.2%+8.2%-19.6%+15.9%+19.5%+8.2%-
EBITDA8,8886,7204,04510,0269,2058,1146,150
EBITDA margin+17.2%+14.4%+9.4%+18.7%+19.9%+21.0%+17.2%
Profit before tax3,157829(2,087)5,1504,9664,1812,764
Net profit1,785890(1,054)3,6743,8483,0502,221
Net profit margin+3.4%+1.9%-2.5%+6.9%+8.3%+7.9%+6.2%
EPS (₹)22.7511.28(16.00)47.6047.4037.5323.22
Balance sheet
Total assets65,39163,28663,06560,19856,52349,93552,051
Net worth34,69629,21324,80726,85824,66120,88719,282
Total debt23,57625,09929,75423,93926,74624,51929,388
Cash & bank6,0869,5376,0366,0976,1204,8536,752
Net working capital13,80016,57116,96316,02515,20712,19913,986
Cash flow
Cash from operations7,85510,1512,3217,7516,4967,2128,739
Cash from investing(1,475)(1,823)(2,509)(1,354)(3,575)(2,426)(2,666)
Cash from financing(9,883)(4,793)164(6,227)(1,921)(6,713)(2,175)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11,86010,18118,33512,26912,0199,21615,57310,907
Revenue growth (YoY)-1.3%+10.5%+17.7%+12.5%+8.4%+1.6%--
Other income18621717892.00392161107170
EBITDA2,0671,3583,4652,1801,9471,3872,8891,602
EBITDA margin+17.4%+13.3%+18.9%+17.8%+16.2%+15.0%+18.6%+14.7%
Depreciation819832915827771731705688
Interest8198528367747841,007914730
Profit before tax615(109)1,892671784(190)1,377354
Tax163(36.00)598181172(14.00)298(499)
Net profit452(73.00)1,294490612(176)1,079853
EPS (₹)4.990.1212.574.696.74(1.94)11.159.70
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue5,7485,3305,3989,03216,44911,3459,641
Revenue growth+7.8%-1.3%-40.2%-45.1%+45.0%+17.7%-
EBITDA3581524018522,0511,6051,195
EBITDA margin+6.2%+2.9%+7.4%+9.4%+12.5%+14.2%+12.4%
Profit before tax1,0132,3411,2481,0831,261434538
Net profit8358021,2099511,180228470
Net profit margin+14.5%+15.1%+22.4%+10.5%+7.2%+2.0%+4.9%
EPS (₹)9.2936.9716.1113.0015.372.886.03
Balance sheet
Total assets15,59014,08914,4779,70211,1949,1189,139
Net worth14,03612,0217,5307,0688,2017,7868,024
Total debt8695971,8526171,7781,3291,112
Cash & bank108137192739825334163
Net working capital5,5013,2731,1341,1612,3041,3231,162
Cash flow
Cash from operations(2,243)(923)(411)1,6672,3491,8201,773
Cash from investing783843(462)1,210(1,481)(1,175)(435)
Cash from financing1,38538.00325(2,689)(643)(502)(1,277)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,8261,3971,1861,3901,5121,6602,0111,427
Revenue growth (YoY)+20.8%-15.8%-41.0%-2.6%+38.7%+107.0%--
Other income69.0012341774.0032194.001,867378
Total expenses1,7131,3501,0811,3391,4031,5672,0811,291
EBITDA11347.0010551.0010993.00(70.00)136
EBITDA margin+6.2%+3.4%+8.9%+3.7%+7.2%+5.6%-3.5%+9.5%
Depreciation26.0025.0028.0032.0032.0033.0034.0039.00
Interest24.0025.0029.0032.0043.0022.0051.0056.00
Profit before tax13212046561.003551321,712419
Tax33.0031.0010629.0083.0010.00(27.00)(573)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 12 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11,86010,18118,33512,26912,0199,21615,57310,907
Revenue growth (YoY)-1.3%+10.5%+17.7%+12.5%+8.4%+1.6%--
Other income18621717892.00392161107170
EBITDA2,0671,3583,4652,1801,9471,3872,8891,602
EBITDA margin+17.4%+13.3%+18.9%+17.8%+16.2%+15.0%+18.6%+14.7%
Depreciation819832915827771731705688
Interest8198528367747841,007914730
Profit before tax615(109)1,892671784(190)1,377354
Tax163(36.00)598181172(14.00)298(499)
Net profit452(73.00)1,294490612(176)1,079853
EPS (₹)4.990.1212.574.696.74(1.94)11.159.70
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue51,83946,63743,09853,57646,24038,69435,756
Revenue growth+11.2%+8.2%-19.6%+15.9%+19.5%+8.2%-
Other income914486483634415300107
Total expenses42,95139,91739,05343,55037,03530,58029,606
Employee cost5,8075,3094,6825,0564,6223,7123,391
EBITDA8,8886,7204,04510,0269,2058,1146,150
EBITDA margin+17.2%+14.4%+9.4%+18.7%+19.9%+21.0%+17.2%
Depreciation3,2442,7502,7632,5472,3592,1732,012
Interest3,4013,6273,8522,9632,2952,0601,481
Profit before tax3,157829(2,087)5,1504,9664,1812,764
Tax9379.00(209)736529686586
Net profit1,785890(1,054)3,6743,8483,0502,221
Net profit margin+3.4%+1.9%-2.5%+6.9%+8.3%+7.9%+6.2%
EPS (₹)22.7511.28(16.00)47.6047.4037.5323.22
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital169159150150153153153
Reserves & surplus34,52729,05424,65726,70824,50820,73419,129
Shareholders' funds (net worth)34,69629,21324,80726,85824,66120,88719,282
Minority interest6,5738,6137,8998,5714,6473,6933,312
Secured loans20519841883.00364302335
Unsecured loans23,37124,90129,33623,85626,38224,21729,053
Total debt23,57625,09929,75423,93926,74624,51929,388
Total liabilities65,39163,28663,06560,19856,52349,93552,051
Assets
Gross block66,45059,09757,18954,76849,84847,04045,704
Net block42,15339,08439,05638,71336,19334,76535,321
Capital work in progress3,1472,5462,9652,8182,5012,1172,073
Investments2,6662,3282,1541,6151,922618558
Inventories12,67610,31612,77613,98513,0789,4227,850
Sundry debtors17,87415,50516,35418,22415,32812,14511,867
Cash & bank balances6,0869,5376,0366,0976,1204,8536,752
Loans & advances4,8923,9393,8723,6364,3623,6132,772
Total current assets41,52839,29739,03841,94238,88830,03329,241
Total current liabilities27,72822,72622,07525,91723,68117,83415,255
Net working capital13,80016,57116,96316,02515,20712,19913,986
Total assets65,39163,28663,06560,19856,52349,93552,051
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash9,4785,9435,9675,7974,7976,7242,826
Net cash from operating activities7,85510,1512,3217,7516,4967,2128,739
Net cash from investing activities(1,475)(1,823)(2,509)(1,354)(3,575)(2,426)(2,666)
Net cash from financing activities(9,883)(4,793)164(6,227)(1,921)(6,713)(2,175)
Net change in cash(3,503)3,535(24.00)1701,000(1,927)3,898
Closing cash6,0869,5376,0366,0976,1204,8536,752
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+11.2%+8.2%-19.6%+15.9%+19.5%+8.2%-
EBITDA growth+32.3%+66.1%-59.7%+8.9%+13.5%+31.9%-
PBT growth+280.8%+9998.0%-+3.7%+18.8%+51.3%+55.9%
Net income growth+100.6%+184.4%-128.7%-4.5%+26.2%+37.3%-
Revenue CAGR (3Y)-1.1%+0.3%+3.7%+14.4%+28.4%+30.6%+29.9%
EBITDA CAGR (3Y)-3.9%-10.0%-20.7%+17.7%+39.9%+34.3%+29.1%
Profitability & leverage
Net income margin+4.3%+1.8%-4.4%+8.2%+9.6%+9.0%+6.1%
Return on capital employed+11.6%+8.7%+3.8%+15.7%+14.8%+13.1%+10.5%
Return on net worth+7.0%+3.0%-6.7%+17.1%+19.5%+17.4%+15.4%
Debt / equity0.761.021.040.981.131.341.72
Long-term debt / equity0.560.820.900.850.991.261.60
Interest cover60.2691.36300.4739.6233.5234.6735.79
Efficiency & per share
Fixed asset turnover0.830.800.771.020.950.830.82
Inventory turnover4.514.043.223.964.114.484.21
Debtors turnover3.112.932.493.193.373.223.04
EPS (₹)22.7511.28(16.00)47.6047.4037.5323.22
Dividend per share (₹)6.006.001.0010.0010.0010.006.00
Book value per share (₹)410.60367.46330.76358.11322.37273.03252.05
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,8261,3971,1861,3901,5121,6602,0111,427
Revenue growth (YoY)+20.8%-15.8%-41.0%-2.6%+38.7%+107.0%--
Other income69.0012341774.0032194.001,867378
Total expenses1,7131,3501,0811,3391,4031,5672,0811,291
EBITDA11347.0010551.0010993.00(70.00)136
EBITDA margin+6.2%+3.4%+8.9%+3.7%+7.2%+5.6%-3.5%+9.5%
Depreciation26.0025.0028.0032.0032.0033.0034.0039.00
Interest24.0025.0029.0032.0043.0022.0051.0056.00
Profit before tax13212046561.003551321,712419
Tax33.0031.0010629.0083.0010.00(27.00)(573)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue5,7485,3305,3989,03216,44911,3459,641
Revenue growth+7.8%-1.3%-40.2%-45.1%+45.0%+17.7%-
Other income9062,5551,121850631113506
Total expenses5,3905,1784,9978,18014,3989,7408,446
Employee cost238189115369767685646
EBITDA3581524018522,0511,6051,195
EBITDA margin+6.2%+2.9%+7.4%+9.4%+12.5%+14.2%+12.4%
Depreciation1251351304311,044977891
Interest126231144188377307272
Profit before tax1,0132,3411,2481,0831,261434538
Tax228(598)40.0010885.0021477.00
Net profit8358021,2099511,180228470
Net profit margin+14.5%+15.1%+22.4%+10.5%+7.2%+2.0%+4.9%
EPS (₹)9.2936.9716.1113.0015.372.886.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital169159150150153153153
Reserves & surplus13,86711,8627,3806,9188,0487,6337,871
Shareholders' funds (net worth)14,03612,0217,5307,0688,2017,7868,024
Secured loans0.000.000.0085.00363301251
Unsecured loans8695971,8525321,4151,028861
Total debt8695971,8526171,7781,3291,112
Total liabilities15,59014,08914,4779,70211,1949,1189,139
Assets
Gross block2,3222,2102,0808,82812,07811,22710,094
Net block7917497384,3195,4775,5985,354
Capital work in progress40.00128118867909722886
Investments5,9675,5333,6873,2082,3741,4411,406
Inventories4854403461,6772,9291,9431,316
Sundry debtors3,3133,6942,2495,7135,5674,0463,161
Cash & bank balances108137192739825334163
Loans & advances3,9562,8547831,1871,3259341,046
Total current assets7,8627,1253,5709,31610,6467,2575,686
Total current liabilities2,3613,8522,4368,1558,3425,9344,524
Net working capital5,5013,2731,1341,1612,3041,3231,162
Total assets15,59014,08914,4779,70211,1949,1189,139
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash10414669450628113877.00
Net cash from operating activities(2,243)(923)(411)1,6672,3491,8201,773
Net cash from investing activities783843(462)1,210(1,481)(1,175)(435)
Net cash from financing activities1,38538.00325(2,689)(643)(502)(1,277)
Net change in cash(75.00)(42.00)(548)18822514361.00
Closing cash108137192739825334163
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+7.8%-1.3%-40.2%-45.1%+45.0%+17.7%-
EBITDA growth+135.5%-62.1%-52.9%-58.5%+27.8%+34.3%-
PBT growth-56.7%+87.6%+15.2%-14.1%+190.6%-19.3%+10.7%
Net income growth+4.1%-33.7%+27.2%-19.4%+418.5%-51.5%-
Revenue CAGR (3Y)-14.0%-31.3%-21.9%-2.2%+23.8%+16.0%+11.6%
EBITDA CAGR (3Y)-25.1%-58.0%-37.0%-10.7%+34.9%+19.4%+10.0%
Profitability & leverage
Net income margin+13.7%+55.1%+22.4%+10.8%+7.2%+1.9%+4.8%
Return on capital employed+7.7%+1.0%+9.1%+8.1%+16.1%+8.1%+8.6%
Return on net worth+6.0%+8.2%+16.6%+12.5%+14.7%+2.8%+5.8%
Debt / equity0.060.130.170.160.190.150.17
Long-term debt / equity0.000.000.000.010.030.060.06
Interest cover54.081,358.8253.1444.6637.4448.8989.47
Efficiency & per share
Fixed asset turnover2.542.480.990.861.411.061.01
Inventory turnover12.4313.565.343.926.756.966.06
Debtors turnover1.641.791.361.603.423.153.27
EPS (₹)9.2936.9716.1113.0015.372.886.03
Dividend per share (₹)6.006.001.0010.0010.0010.006.00
Book value per share (₹)166.11151.21100.4094.24107.20101.78104.89

Investments & Acquisitions by UPL

UPL has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Arysta LifeScience, BioQuim and Bioseen.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Kudos Chemie Limited
Specialty chemicals are manufactured for beverage and pharmaceutical ingredients.
kudoschemie.comPatiala, India1988Jun 2022$5.13M
Arysta LifeScience
Chemical and bio-fertilizers are produced and supplied by the company.
arystalifescience.comCary, United States2001Jan 2021••••
Bioseen
Strategic consulting and idea generation services are provided to clients.
yoloo.cnBeijing, China2004Apr 2020••••
BioQuim
Crop protection products are manufactured and supplied globally.
bioquimcr.comCurridabat, Costa Rica1987Nov 2018••••
Cerexagri
Crop protection and post-harvest agrichemicals are manufactured and wholesaled.
cerexagri.comKing Of Prussia, United States2006Jun 2007$140M
Swal Corporation
Agrochemicals are manufactured and supplied to agriculture.
swal.inMumbai, India1979Jun 2005$5.5M
Premium access

Complete acquisition details for UPL

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of UPL

11 dated milestones of UPL across 53 years, from founding to its latest funding, stage changes and deals.

  1. Founded UPL is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Acquisition Acquires Swal Corporation.
  4. Funding First funding round of $150.0M.
  5. Acquisition Acquires Cerexagri.
  6. Acquisition Acquires Arysta LifeScience.
  7. Funding Latest funding round, Post-IPO,.
  8. Acquisition Acquires BioQuim.
  9. Acquisition Acquires Bioseen.
  10. Acquisition Acquires Arysta LifeScience.
  11. Acquisition Acquires Kudos Chemie Limited.

Web traffic of UPL

The website of UPL (upl-ltd.com) receives about 93.4K visits a month and ranks #350,074 among all websites worldwide, #4,147 in Chemical Industry.

  • Monthly visits
    93.4K

    ▼ 18.9% vs previous month

  • Unique visitors
    58.7K

    per month

  • Global rank
    #350,074

    among all websites

  • Category rank
    #4,147

    Heavy Industry and Engineering · Chemical Industry

Similar websites

Websites whose visitors overlap most with UPL. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
Indian Chemical News
indianchemicalnews.com
100%
#555,272View details
Grauer & Weil India
growel.com
93%
15.4K#1,650,930View details
Cultree
cultree.in
93%
#609,817View details
uplcorp.com
uplcorp.com
84%
#313,928–
agroquimicos-organicosplm.com
agroquimicos-organicosplm.com
60%
#953,414–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 25 similar websites and full traffic analytics for UPL

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 25 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Upl

UPL: Jefferies on UPL maintains Buy, Target Price Rs 610; Q2FY27 EBITDA and PAT exceeded estimates, while revenue remained broadly in line as adverse weather weighed on volumes and foreign exchange movements supported performance. Advanta and UPL SAS delivered strong EBITDA growth, although working capital and net debt increased YoY. UPL retained its FY27 guidance, implying mid-teens growth in 2HFY27, while Jefferies projects 15% EBITDA growth for FY27. The stock has corrected 35% since the restructuring announcement.
Exchange Update • 9 days ago
UPL: HSBC on UPL; Q2FY27 results were ahead of estimates, with crop protection facing headwinds while Advanta and specialty chemicals performed well. FY27 revenue and EBITDA growth guidance was retained, but management provided no definitive update on the reorganisation. UPL trades at 5.3x FY28E EV/EBITDA.
Exchange Update • 9 days ago
UPL: Management Confident in FY27 Revenue Growth of 7% to 11% and EBITDA Increase of 10% to 14%, Even with Tough Conditions; Company Keeps Medium-Term Net Debt to EBITDA Target at 1.5X, Year-End Figure Uncertain Due to Economic Factors.
Exchange Update • 9 days ago
UPL: Superform's Specialty Chemicals Unit Anticipates Ongoing Revenue and EBIT Growth Over the Next Two Quarters Boosted by Volume, New Products, and Contract Manufacturing.
Exchange Update • 9 days ago
UPL: Q2 CONS NET PROFIT 4.2B RUPEES VS 5.5B (YOY)
Exchange Update • 10 days ago
UPL: Q2 EBITDA 22B RUPEES VS 20B (YOY); Q2 EBITDA MARGIN 18.55% VS 16.65% (YOY)
Exchange Update • 10 days ago
UPL: Q2 REVENUE 119B RUPEES VS 120B (YOY)
Exchange Update • 10 days ago
UPL: Reports Debt Rise of About Rs 5000 Crore in H1 FY27
Exchange Update • 10 days ago
UPL: HSBC on UPL Maintains Buy, cuts Target Price to ₹670 from ₹880; the analyst meet highlighted growth opportunities in super-specialty chemicals, while lower valuation multiples and a holding-company discount temper the valuation.
Exchange Update • 1 month ago
UPL: Kotak Institutional Equities on UPL Upgrades to Add, Target Price ₹550; applies a 20% holding-company discount following the stock’s recent correction, while noting that changes to management’s reorganisation plan could drive upside to fair value.
Exchange Update • 1 month ago
Premium access

Complete news archive for UPL

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Articles about UPL on our blog

Frequently Asked Questions about UPL

UPL was founded in 1969 and raised its 1st funding round 37 years after it was founded.

UPL is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Mike Frank is the CEO of UPL, as recorded in our data.

UPL has 132 employees.

The primary company behind UPL, Upl Limited, reported revenue of ₹52,753 Cr for FY 2026, up 11% year on year.

UPL was founded in 1969 in Mumbai, India, and operates in the agriculture sector. Crop protection solutions and smart farming practices are offered to farmers and agribusinesses. Emphasis is placed on OpenAg initiatives to support sustainable methods and innovative technologies. Operations extend internationally, with a focus on transforming agricultural processes through evidence-based approaches. Leadership is shared among co-CEOs, including Vikram Shroff.

Yes, UPL is publicly traded on NSE under the ticker symbol UPL.

UPL has made 6 acquisitions, including Arysta LifeScience, BioQuim, and Bioseen.

UPL has 1 investor. Key investors include Nerka Chemicals.

UPL operates through Upl Limited.

The legal entities of UPL currently have 11 directors, including Hardeep Singh, Jaidev Rajnikant Shroff, Vikram Rajnikant Shroff and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available